Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
10/2008
10/22/2008CN101289498A Cyclic peptide with -val-sta-leu- residue segment and used as immunity inhibitor and synthetic process thereof
10/22/2008CN101289497A Cyclic peptide with -Ile-Sta-Sta-Tyr- residue segment and used as immunity inhibitor and synthetic process thereof
10/22/2008CN101289496A Epitope screening method capable of exciting anti-mycobacterium tuberculosis protective immunological reaction of body and uses
10/22/2008CN101289494A Cyclic peptides with vasodilator action, preparation and uses thereof
10/22/2008CN101289493A Process for abstracting high-purity hemoglobin from pig blood
10/22/2008CN101289394A Process for abstracting chlorogenic acid and separating protein and small peptide form sunflower meal
10/22/2008CN100427597C Prokaryotic expression engineering bacteria for producing human recombinant interleukin-15 and its purifying method
10/22/2008CN100427506C Process for preparation of polypeptides of interest from fusion polypeptides
10/22/2008CN100427502C Antineoplastic oligopeptide and its preparation method and application
10/21/2008US7439336 Aqueous two-phase partitioning via polyethylene glycol phase and (Na2)SO4
10/21/2008US7439333 Vascular endothelial growth factor 2
10/21/2008US7439325 PRO6001 polypeptides
10/21/2008US7439323 Cysteine-containing peptides having antioxidant properties
10/21/2008US7439228 Bioactive peptides
10/21/2008US7439224 Indications of mannan-binding lectin (MBL) in the treatment of immuno-compromised individuals
10/21/2008US7439222 Process and systems for peptide synthesis
10/21/2008US7439075 Method and device for withdrawing suspended microparticles from a fluidic microsystem
10/21/2008US7439040 Binding a polypeptide having an anchor region and a protease recognition site to a solid support comprising a protein via a protein-protein interaction; industrial scale drug screening for hepatitis C protease inhibitors; high speed
10/21/2008US7439025 Antibodies binding a gamma carboxyglutamic acid displaying epitope
10/21/2008US7439017 Assays for measuring nucleic acid binding proteins and enzyme activities
10/21/2008US7438806 Affinity matrices with enhanced visibility for molecular pull-down and immunoprecipitation applications
10/21/2008CA2330974C Energy transfer assay method and reagent
10/16/2008WO2008124139A1 High pressure inclusion body solubilization in the presence of a protease
10/16/2008WO2008124134A2 High-pressure refolding of proteins in the presence of binding partners
10/16/2008WO2008123033A1 Method for production of proteolytic product containing branched amino acid at high content
10/16/2008WO2008122089A1 Method of purifying recombinant peptides by selective precipitation
10/16/2008WO2008100578A3 Method of isolating antibodies by precipitation
10/16/2008WO2008091408A3 Circulating renalase and methods of increasing same
10/16/2008WO2008088548A3 Disintegrin variants and pharmaceutical uses thereof
10/16/2008WO2008073382A3 Hsp90 and ip6k2 binding
10/16/2008WO2008066629A3 Methods for quantitative proteome analysis of glycoproteins
10/16/2008WO2008066608A3 A secreted luciferase fluorescent protein conjugate nucleic acid construct and uses thereof
10/16/2008WO2008049106A3 Process for preparing unaggregated antibody fc domains
10/16/2008WO2008033556A3 High pressure treatment of proteins for reduced immunogenicity
10/16/2008WO2008008975A8 Refolding of recombinant proteins
10/16/2008WO2007126823A3 Modified metallothioneins and methods for screening and treatment of diseases associated with oxidative stress
10/16/2008WO2007103469A3 Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
10/16/2008US20080255342 Protein purification method
10/16/2008US20080255339 Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities
10/16/2008US20080255027 Purification of biomolecules such as proteins, polypeptides, antibodies and the like by use of a stimuli responsive polymer, such as a solubilized or soluble polymer to capture the desired biomolecules from a solution/suspension by precipitation mechanism and then to further purify them
10/16/2008US20080254551 Using support immobilized immunmoglobulin fusions as separation and classification tools in screening fluids for preferential analytes
10/16/2008US20080254546 Arsenic complexes; transmetallization
10/16/2008US20080254512 Hybrid immunoglobulins with moving parts
10/16/2008US20080254461 METHODS FOR ISOLATING AND CHARACTERIZING ENDOGENOUS mRNA-PROTEIN (mRNP) COMPLEXES
10/16/2008US20080254044 Immunoglobulin fusion comprising cohesin-dockerin for use in targeting, treating and preventing cell proliferative disorders
10/16/2008US20080254028 Caspase-8 interacting polypeptide (Cari) for use in identifying modulators for prevention and treatment of autoimmune, inflammatory, connective tissue and liver disorders
10/16/2008US20080254018 Solid support comprising stably conjugated neovascularizing protein for use in identifying modulators of cell proliferation
10/16/2008US20080253992 Using hydrophobic interaction chromatography to recover therapeutic fusion protein for use in treatment of injuries associated with ischemia, trauma, inflammation and contact with toxic substances
10/16/2008US20080253964 Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules
10/15/2008EP1980570A2 Purification of Antibodies
10/15/2008EP1979372A2 Methods of labeling transiently expressed proteins in large-scale eukaryotic cell cultures
10/15/2008EP1979371A2 Method of producing a modified (poly)peptide
10/15/2008EP1979370A1 SELECTIVE ENZYMATIC HYDROLYSIS OF C-TERMINAL tert-BUTYL ESTERS OF PEPTIDES
10/15/2008EP1455920B1 Separation method
10/15/2008EP1421103B1 Method for making acylated polypeptides
10/15/2008EP1325340B1 Identification of protein binding sites
10/15/2008EP1272517B1 Multiprotein-complexes comprising a nmda receptor and uses thereof
10/15/2008EP1151117B1 Intein-mediated protein ligation of expressed proteins
10/15/2008CN101287746A Differentially protected orthogonal lanthionine technology
10/15/2008CN101285221A Preparation method of glycosylated nano-fibre for identifying proteinicsubstance and applications
10/15/2008CN101285066A Process for heterologously expressing and purifying human glucose transporters GLUT1, GLUT2 and GLUT3
10/15/2008CN101284872A Antioxidation active peptides and method for preparing same
10/15/2008CN101284871A Cyclic peptides with ¿CPro-Sta-Tyr- residue fragment as immunity inhibitor and synthesis process thereof
10/15/2008CN101284864A Applications of ZrO2 in the process for concentrating and purifying phosphorylated peptides
10/15/2008CN101284863A Preparation method of solid phase synthesis cetrorelix
10/15/2008CN101284862A Synthetic method of L-carnosine
10/15/2008CN101284224A Expanded bed adsorption medium with sulfhydryl ethylpyridine and sulfone group as ligand separation antibody and preparation method
10/15/2008CN100425331C Continuous free flow electrophoresis device composed of a plurality of specific sub-chambers separated by films
10/14/2008US7435798 Antibodies to a polypeptide encoded by a nucleic acid overexpressed in normal stomach, normal skin and kidney tumor
10/14/2008US7435794 Methods and compositions for selectively cleaving DNA containing duplex nucleic acids in a complex nucleic acid mixture, and nuclease compositions for use in practicing the same
10/14/2008US7435792 Hybrid proteins that migrate retrogradely and transynaptically into the CNS
10/14/2008US7435791 Preparing amino acid sequences in organic solvent or mixture of organic solvents; in vitro translation; mimetics
10/14/2008US7435569 Method of forming a molded protein matrix for use in a sensor
10/14/2008US7435540 Drug screening; prion disease; Creutzfeldt-Jakob disease; for detecting and for purifying PrPSc
10/14/2008CA2457584C Enhancing solubility of iron amino acid chelates and iron proteinates
10/14/2008CA2255865C Synthesis of soluble beta-sheet forming peptides
10/14/2008CA2142780C Process for obtaining insulin having correctly linked cystine bridges
10/09/2008WO2008121340A1 Methods for diagnosing ovarian cancer
10/09/2008WO2008120801A1 Method of producing antithrombin composition
10/09/2008WO2008119203A1 A purified recombinant batroxobin with high specific activity
10/09/2008WO2008119186A1 Method for selective fractionation of growth factors from dairy products
10/09/2008WO2008119185A1 Process for the manufacture of a dairy-based anti-inflammatory composition
10/09/2008WO2008119181A1 Stabilized gold nanoparticles and methods of making the same
10/09/2008WO2008073146A3 Method and apparatus for pyrolysis-induced cleavage in peptides and proteins
10/09/2008WO2008060307A3 Methods of labeling transiently expressed proteins in large-scale eukaryotic cell cultures
10/09/2008WO2008014400A3 Crohn disease susceptibility gene
10/09/2008WO2007101028A3 Method to produce enzymatically active recombinant endonucleases
10/09/2008WO2006116423A3 Compositions and methods for cancer immunotherapy
10/09/2008US20080249451 Replacement of cystine disulfide bonds with lanthionine residues; incubation keratin in solvent
10/09/2008US20080249289 Manufacture of a Chromatography Matrix
10/09/2008US20080249288 Recombinantly preparing antibody fusion for targeting and/or treating metabolic disorders
10/09/2008US20080249287 expressing polypeptides in bacteria and contacting with a refolding buffer comprising potassium or sodium phosphate, guanidine hydrochloride, arginine, Tween-80, oxidized glutathione and reduced glutathione, effective to induce folding of the denatured polypeptide
10/09/2008US20080249286 High-pressure refolding of proteins in the presence of binding partners
10/09/2008US20080249285 Method For Affinity Purification
10/09/2008US20080249014 Micro(dia)filtration of a cell homogenate, extracting the retenate using a buffer solution containing at least one detergent, ion exchange, hydroxyapatite column chromatography; Borrelia lipoproteins, membrane proteins; industrial scale
10/09/2008US20080248992 Inactivated alpha-cobratoxin; neurotoxins affecting neurojunction, ion channels; inactive bioactive polypeptide of anti-immunodeficiency virus immunokine binding to a cellular protein that reduces HIV infection; identification of a biologic anticholinergic agent capable of binding to a cellular protein
10/09/2008US20080248961 Removal of a compound from a mixture of related structures of a combinatorial library using a molecularly imprinted polymer as steroid adsorbents
10/09/2008US20080248584 Trityl derivatives for enhancing mass spectrometry
10/09/2008US20080248548 Regulating conformation and biological activity via switch control ligand-pocket interaction; drug screening; bioinformatics
10/09/2008US20080248521 Enhanced cell-free synthesis of active proteins containing disulfide bonds